ND Biosciences

ND Biosciences awarded a grant from The Michael J. Fox Foundation to accelerate the development of its assays for early diagnosis of Parkinson’s disease and monitoring disease progression

ND Biosciences awarded a grant from The Michael J. Fox Foundation to accelerate the development of its assays for early diagnosis of Parkinson’s disease and monitoring disease progression ND Biosciences announced today that it was awarded a grant by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to accelerate its diagnostics rese

Read More

ND Biosciences announces partnership with The Michael J. Fox Foundation for Parkinson’s Research to make available unique Synuclein proteoforms to the scientific community

ND-BioSciences Announces partnership with The Michael J. Fox Foundation for parkinson’s research to make available unique synuclein proteoforms to the scientific community Given ND Biosciences’ commitment to deploy its expertise, technical capabilities and integrated platforms to accelerate the discovery and validation of novel targets and

Read More

ND Biosciences awarded a grant from The Michael J. Fox Foundation to develop more accurate assays for early diagnosis of Parkinson’s disease and differentiating Parkinson’s disease from other neurodegenerative diseases

ND BioSciences, a Swiss-based biotechnology company that was

Read More

Check out the interview of our co-founder Bilal Fares with Sejelas, where he discusses ND Biosciences’ evolution, scientific innovation, and the realities of managing a biotech startup.​

ND BioSciences, the Swiss biotech co-founded by Prof. Hilal Lashuel, the director of the laboratory of molecular and chemical biology

Read More

ND Biosciences est la sixième entreprise à rejoindre le StartLab

La start-up qui veut combattre les maladies neurodégénératives par des traitements novateurs

Read More

The Epfl Spin-Off ND Biosciences Receives Chf 100’000 To Fight Neurodegenerative Diseases

The biotech start-up based at Biopôle is developing innovative technologies for early diagnostics and therapies

Read More

ND Biosciences’ founders publish a systematic and critical review of Parkinson’s disease models

The development of disease models that recapitulate the key pathological and clinical features of neurodegenerative diseases

Read More

Award winning ND Biosciences joins StartLab

ND BioSciences, the Swiss biotech co-founded by Prof. Hilal Lashuel, the director of the laboratory of molecular and chemical biology

Read More

ND Biosciences awarded a new grant from The Michael J. Fox Foundation to develop more accurate and sensitive assays for quantifying α-Synuclein

ND BioSciences, a Swiss-based biotechnology company that was

Read More

ND Biosciences awarded a grant from The Michael J. Fox Foundation to help advance the foundation’s α-Synuclein biomarkers discovery and validation programs

ND BioSciences, a Swiss-based biotechnology company that was

Read More